Angiogenesis within the duodenum of patients with cirrhosis is modulated by mechanosensitive Kruppel-like factor 2 and microRNA-126

Liver International

Volumn 32, Issue 8, 2012, Pages 1222-1232

  Kobus, Karolina ^a   Kopycinska, Justyna ^a   Kozlowska Wiechowska, Anna ^b   Urasinska, Elzbieta ^a   Kempinska Podhorodecka, Agnieszka ^a   Haas, Tara L ^c   Milkiewicz, Piotr ^a   Milkiewicz, Malgorzata ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Department of Endoscopy   (Poland)

^c York University   (Canada)

Author keywords

Angiogenesis; KLF 2; MicroRNA 126; Portal hypertension; Splanchnic circulation

Indexed keywords

ANGIOPOIETIN 2; CD31 ANTIGEN; HEME OXYGENASE 1; KRUPPEL LIKE FACTOR 2; MESSENGER RNA; MICRORNA 126; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DUODENUM; DUODENUM BIOPSY; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNODETECTION; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLANCHNIC BLOOD FLOW; WESTERN BLOTTING;

ANTIGENS, CD31; ANTIGENS, CD34; DUODENUM; FEMALE; HEME OXYGENASE-1; HUMANS; HYPERTENSION, PORTAL; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER CIRRHOSIS; MALE; MECHANOTRANSDUCTION, CELLULAR; MICRORNAS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; SPLANCHNIC CIRCULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865159109     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02791.x     Document Type: Article

References (44)

1. Colle I, Geerts AM, Van Steenkiste C, Van Vlierberghe H. Hemodynamic changes in splanchnic blood vessels in portal hypertension. Anat Rec (Hoboken) 2008; 291: 699-713.
2. Groszmann RJ, Loureiro-Silva MM, Tsai M. The Biology of Portal Hypertension, 4th edn. New York: Lippincott Williams&Wilkins, 2001.
3. Sumanovski LT, Battegay E, Stumm M, van der Kooij M, Sieber CC. Increased angiogenesis in portal hypertensive rats: role of nitric oxide. Hepatology 1999; 29: 1044-9.
4. Bosch J, Abraldes JG, Fernandez M, Garcia-Pagan JC. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol 2010; 53: 558-67.
5. Fernandez M, Semela D, Bruix J, et al. Angiogenesis in liver disease. J Hepatol 2009; 50: 604-20.
6. Geerts AM, De Vriese AS, Vanheule E, et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int 2006; 26: 889-98.
7. Van SC, Geerts A, Vanheule E, et al. Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension. Gastroenterology 2009; 137: 2112-24.
8. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-95.
9. Milkiewicz M, Ispanovic E, Doyle JL, Haas TL. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 2006; 38: 333-57.
10. Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am 1992l; 21: 1-14.
11. Fernandez M, Mejias M, Garcia-Pras E, et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 2007; 46: 1208-17.
12. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
13. Hernandez-Guerra M, Garcia-Pagan JC, Bosch J. Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension. J Clin Gastroenterol 2005; 39: S131-7.
14. Thurston G, Rudge JS, Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460-3.
15. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-8.
16. Senbanerjee S, Lin Z, Atkins GB, et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 2004; 199: 1305-15.
17. Bhattacharya R, Senbanerjee S, Lin Z, et al. Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2. J Biol Chem 2005; 280: 28848-51.
18. Parmar KM, Larman HB, Dai G, et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 2006; 116: 49-58.
19. Fish JE, Srivastava D. MicroRNAs: opening a new vein in angiogenesis research. Sci Signaling 2009; 2: e1.
20. Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008; 15: 272-84.
21. Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261-71.
22. Milkiewicz M, Roudier E, Doyle JL, et al. Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle. Am J Pathol 2011; 178: 935-44.
23. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-38.
24. Holland-Fischer P, Gronbaek H, Sandahl TD, et al. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS. Gut 2011; 60: 1389-93.
25. Mejias M, Garcia-Pras E, Tiani C, et al. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 2009; 49: 1245-56.
26. Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 2004; 126: 886-94.
27. Fernandez M, Mejias M, Angermayr B, et al. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 2005; 43: 98-103.
28. Gracia-Sancho J, Russo L, Garcia-Caldero H, et al. Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut 2011; 60: 517-24.
29. Melgar-Lesmes P, Tugues S, Ros J, et al. Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats. Gut 2009; 58: 285-92.
30. Milkiewicz M, Hudlicka O, Shiner R, Egginton S, Brown MD. Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat. J Physiol 2006; 577: 671-8.
31. Dekker RJ, van SS, Fontijn RD, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 2002; 100: 1689-98.
32. Groenendijk BC, Hierck BP, Vrolijk J, et al. Changes in shear stress-related gene expression after experimentally altered venous return in the chicken embryo. Circ Res 2005; 96: 1291-8.
33. Gracia-Sancho J, Russo L, Garcia-Caldero H, et al. Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut 2011; 60: 517-24.
34. Kawanami D, Mahabeleshwar GH, Lin Z, et al. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. J Biol Chem 2009; 284: 20522-30.
35. van Thienen JV, Fledderus JO, Dekker RJ, et al. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res 2006; 72: 231-40.
36. Nicoli S, Standley C, Walker P, et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010; 464: 1196-200.
37. Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008; 117: 231-41.
38. Angermayr B, Mejias M, Gracia-Sancho J, et al. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. J Hepatol 2006; 44: 1033-9.
39. Fernandez M, Bonkovsky HL. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999; 29: 1672-9.
40. Fernandez M, Lambrecht RW, Bonkovsky HL. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. J Hepatol 2001; 34: 812-7.
41. Ali F, Hamdulay SS, Kinderlerer AR, et al. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost 2007; 5: 2537-46.
42. Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1074-81.
43. Tazi KA, Barriere E, Moreau R, et al. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis. Gastroenterology 2002; 122: 1869-77.
44. Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology 2003; 125: 1452-61.